JP2004107333A5 - - Google Patents

Download PDF

Info

Publication number
JP2004107333A5
JP2004107333A5 JP2003301176A JP2003301176A JP2004107333A5 JP 2004107333 A5 JP2004107333 A5 JP 2004107333A5 JP 2003301176 A JP2003301176 A JP 2003301176A JP 2003301176 A JP2003301176 A JP 2003301176A JP 2004107333 A5 JP2004107333 A5 JP 2004107333A5
Authority
JP
Japan
Prior art keywords
arg
cys
tyr
cit
glutamic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2003301176A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004107333A (ja
JP4781621B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2003301176A priority Critical patent/JP4781621B2/ja
Priority claimed from JP2003301176A external-priority patent/JP4781621B2/ja
Publication of JP2004107333A publication Critical patent/JP2004107333A/ja
Publication of JP2004107333A5 publication Critical patent/JP2004107333A5/ja
Application granted granted Critical
Publication of JP4781621B2 publication Critical patent/JP4781621B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2003301176A 2002-08-27 2003-08-26 Cxcr4拮抗薬およびその用途 Expired - Fee Related JP4781621B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2003301176A JP4781621B2 (ja) 2002-08-27 2003-08-26 Cxcr4拮抗薬およびその用途

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2002247843 2002-08-27
JP2002247843 2002-08-27
JP2003301176A JP4781621B2 (ja) 2002-08-27 2003-08-26 Cxcr4拮抗薬およびその用途

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2011060367A Division JP5315372B2 (ja) 2002-08-27 2011-03-18 Cxcr4拮抗薬およびその用途

Publications (3)

Publication Number Publication Date
JP2004107333A JP2004107333A (ja) 2004-04-08
JP2004107333A5 true JP2004107333A5 (cg-RX-API-DMAC7.html) 2006-09-14
JP4781621B2 JP4781621B2 (ja) 2011-09-28

Family

ID=32301222

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003301176A Expired - Fee Related JP4781621B2 (ja) 2002-08-27 2003-08-26 Cxcr4拮抗薬およびその用途

Country Status (1)

Country Link
JP (1) JP4781621B2 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105163749B (zh) * 2013-03-24 2018-03-27 拜欧肯治疗有限公司 治疗骨髓性白血病的方法
MX2017016844A (es) 2015-07-16 2018-08-15 Biokine Therapeutics Ltd Composiciones y procedimientos para tratar cancer.
CA3014530A1 (en) 2016-02-23 2017-08-31 Biolinerx Ltd. Methods of treating acute myeloid leukemia
BR112021008797A2 (pt) * 2018-11-09 2021-08-31 Neopep Pharma Gmbh & Co. Kg Polipeptídeos para o tratamento de síndromes de estresse, imunorreação e derrame

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69416824T2 (de) * 1993-10-14 1999-07-08 Seikagaku Corp., Tokio/Tokyo Polypeptide und daraus hergestellte, gegen hiv wirksame substanzen
DE69914463T2 (de) * 1998-03-13 2004-11-11 The University Of British Columbia, Vancouver Therapeutische chemokine rezeptor antagonisten
CA2389979C (en) * 1999-11-24 2011-08-16 Schering Corporation Methods of inhibiting metastasis
DE60103052T2 (de) * 2000-05-09 2005-03-03 The University Of British Columbia, Vancouver Verwendung von cxcr4 antagonisten zur behandlung von krebs und autoimmunkrankheiten
EP1323730B1 (en) * 2000-09-05 2010-04-21 Biokine Therapeutics Ltd. Novel polypeptides and anti-hiv drugs containing the same

Similar Documents

Publication Publication Date Title
JP2013500990A5 (cg-RX-API-DMAC7.html)
CA3188410A1 (en) Conjugated hepcidin mimetics
RU2004110726A (ru) Применение оксинтомодулина, способ и фармацевтическая композиция для профилактики или лечения избыточной массы тела, способ снижения массы тела
JP2010529957A5 (cg-RX-API-DMAC7.html)
JP2020502183A5 (cg-RX-API-DMAC7.html)
CO5590884A2 (es) Molecula de insulina que tiene una accion en el tiempo prolongada
CA2370289A1 (en) Neuronal exocytosis inhibiting peptides and cosmetic and pharmaceutical compositions containing said peptides
JP2008525430A5 (cg-RX-API-DMAC7.html)
JP2011511753A5 (cg-RX-API-DMAC7.html)
JP2004521123A5 (cg-RX-API-DMAC7.html)
NZ613252A (en) Peptide epoxyketones for proteasome inhibition
HRP20041108B1 (hr) Peptidi povezani sa tumorom koji se vežu na mhc molekule
EP1614675A3 (en) Amino acids with affinity for the alpha-2-delta protein
JP2006506942A5 (cg-RX-API-DMAC7.html)
WO2007027640A3 (en) Stabilized virus-like particles and epitope display systems
EA200501131A1 (ru) Парентеральные композиции пептидов для лечения системной красной волчанки
EP1323730A4 (en) NEW POLYPEPTIDES AND ANTI-HIV DRUGS CONTAINING THEM
WO2007145589A8 (en) Peptides that are capable of binding to amyloid-beta peptide.
CY1112839T1 (el) Πεπτιδια χ-κωνοτοξινες που εχουν ενα αμινοτελικο πυρογλουταμικο οξυ
RU2010128602A (ru) Циклический белок, не содержащий остатков цистеина
ES2377808T3 (es) Péptidos antibacterianos
RU2011133224A (ru) Новые фармацевтические композиции
RU2009103811A (ru) Аналоги вазоактивного интестинального пептида
JP2021506815A5 (cg-RX-API-DMAC7.html)
JP2006505555A5 (cg-RX-API-DMAC7.html)